期刊文献+

新生儿朗格汉斯细胞组织细胞增生症一例 被引量:1

Neonatal Langerhans cell histiocytosis:a case report
原文传递
导出
摘要 本文报告了1例患朗格汉斯细胞组织细胞增生症新生儿的临床表现、辅助检查、诊断及治疗情况。该患儿因生后发现皮疹伴反应差6h入院,入院后通过影像学及皮肤活检、免疫组织化学检查等手段明确诊断。因家长放弃治疗出院,患儿死亡。朗格汉斯细胞组织细胞增生症表现多样,临床尚无特效疗法,主要治疗措施是积极控制感染,以及必要的对症、支持治疗。肺内感染常是朗格汉斯细胞组织细胞增生症致死的原因。感染也能刺激组织细胞增生,而加重原有病变。 We reported a case of neonatal Langerhans cell histiocytosis (LCH)with his clinical manifestations,examinations,diagnosis and treatment.This infant was hospitalized due to the rash and poor response.He was diagnosed as LCH after admission by imaging,skin biopsy and immunohistochemistry.The infant died because his parents refused all possible treatments.At the moment,no effective treatment is available for LCH patients,while the main managements are infection control and necessary supportive care.Pulmonary infections often contribute to the death of LCH patient and can aggravate the situation by stimulating histiocytic hyperplasia.
作者 康文清 王彩君 张耀东 刘大鹏 王颍源 宋俐 Kang Wenqing;Wang Caijun;Zhang Yaodong;Liu Dapeng;Wang Yingyuan;Song Li(Neonatal Intensive Care Unit,Children's Hospital Affiliated to Zhengzhou University,Children's Hospital of Henan Province,Zhengzhou Children's Hospital,Zhengzhou 450018,China;Department of Dermatology,Children's Hospital Affiliated to Zhengzhou University,Children's Hospital of Henan Province,Zhengzhou Children's Hospital,Zhengzhou 450018,China)
出处 《中华围产医学杂志》 CAS CSCD 北大核心 2018年第12期830-833,共4页 Chinese Journal of Perinatal Medicine
关键词 组织细胞增多症 郎格尔汉斯细胞 婴儿 新生 病例报告 Histiocytosis,langerhans-cell Infant,newborn Case reports
  • 相关文献

参考文献2

二级参考文献17

  • 1王宏胜,李军,马伴吟,高怡瑾,陆凤娟,钱晓文.改良DAL-HX83/90方案治疗儿童郎格罕细胞组织细胞增生症24例疗效观察[J].中国小儿血液与肿瘤杂志,2007,12(2):60-63. 被引量:12
  • 2Histiocyte Society. Langerhans cell histiocytosis evaluation and treatment guideline. April,2009. Availabele from : http ://www. heamatologie-amc, nl/odijk/bijlagen.
  • 3Minkov M. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions. Paediatr Drugs, 2011,13 : 75 -86.
  • 4Gadner I-I, Grois N, Arico M, et al. A randomized trial of treatment for multisystem Langerhans' cell histioeytosis. J Pediatr, 2001, 138:728-734.
  • 5treatment ot multisystem Langerhans cell histiocytosis : important prognostic indicator. Med Pediatr Oncol, 2002,39:581- 585.
  • 6Bernard F, Thomas C, Bertrand Y,et al. Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside corobined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction. Eur J Cancer, 2005,41:2682-2689.
  • 7Steiner M, Matthes-Martin S, Attarbaschi A, et al. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced- intensity conditioning. Bone Marrow Transplant, 2005,36: 215- 225.
  • 8Egeler RM, de Kraker J, Vo6te PA. Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution. Med Pediatr Oncol, 1993,21: 265-270.
  • 9Stine KC, Saylors RL, Williams LL, et al. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Med Pediatr Oncol, 1997,29: 288-292.
  • 10Stine KC, Saylors RL, Saccente S, et al. Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis. Pediatr Blood Cancer, 2004,43:81-84.

共引文献67

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部